Corrigendum: Cerebral Cavernous Malformations: Review of the Genetic and Protein–Protein Interactions Resulting in Disease Pathogenesis

Mutations in the genes KRIT1, CCM2, and PDCD10 are known to result in the formation of cerebral cavernous malformations (CCMs). CCMs are intracranial lesions comprised of aberrantly enlarged “cavernous” endothelial channels that can result in cerebral hemorrhage, seizures, and neurologic deficits. Although these genes have been known to be associated with CCMs since the 1990s, numerous discoveries have been made that better elucidate how they and their subsequent protein products are involved in CCM pathogenesis. Since our last review of the molecular genetics of CCM pathogenesis in 2012, breakthroughs include a more thorough understanding of the protein structures of the gene products, involvement with integrin proteins and MEKK3 signaling pathways, the importance of CCM2-PDCD10 interactions, and others. In this review, we highlight the advances that further our understanding of the gene to protein to disease relationships of CCMs.

[1]  M. Malbouyres,et al.  CCM1–ICAP-1 complex controls β1 integrin–dependent endothelial contractility and fibronectin remodeling , 2013, The Journal of cell biology.

[2]  W. Min,et al.  EXCEPTIONAL AGGRESSIVENESS OF CEREBRAL CAVERNOUS MALFORMATION DISEASE ASSOCIATED WITH PDCD10 MUTATIONS , 2014, Genetics in Medicine.

[3]  T. Haystead,et al.  Proteomic identification of the cerebral cavernous malformation signaling complex. , 2007, Journal of proteome research.

[4]  A. Louvi,et al.  Ccm3, a gene associated with cerebral cavernous malformations, is required for neuronal migration , 2014, Development.

[5]  C. Liquori,et al.  Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. , 2003, American journal of human genetics.

[6]  F. Garaci,et al.  Cerebral cavernous malformations associated to meningioma: High penetrance in a novel family mutated in the PDCD10 gene , 2015, The neuroradiology journal.

[7]  M. Ginsberg,et al.  Rap1 and its effector KRIT1/CCM1 regulate β-catenin signaling , 2010, Disease Models & Mechanisms.

[8]  R. Shenkar,et al.  Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity , 2010, The Journal of experimental medicine.

[9]  R. Scott,et al.  Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. , 1998, Human molecular genetics.

[10]  Lan Cheng,et al.  Dynamic regulation of the cerebral cavernous malformation pathway controls vascular stability and growth. , 2012, Developmental cell.

[11]  W. Min,et al.  Molecular Recognition of Leucine-Aspartate Repeat (LD) Motifs by the Focal Adhesion Targeting Homology Domain of Cerebral Cavernous Malformation 3 (CCM3)* , 2011, The Journal of Biological Chemistry.

[12]  W. Min,et al.  Crystal Structure of CCM3, a Cerebral Cavernous Malformation Protein Critical for Vascular Integrity* , 2010, The Journal of Biological Chemistry.

[13]  T. Boggon,et al.  Structural studies of cerebral cavernous malformations 2 (CCM2) reveal a folded helical domain at its C‐terminus , 2013, FEBS letters.

[14]  L. Ferrarini,et al.  Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice , 2015, Proceedings of the National Academy of Sciences.

[15]  Melynda Boerm,et al.  Mekk3 is essential for early embryonic cardiovascular development , 2000, Nature Genetics.

[16]  P. Degan,et al.  KRIT1 Regulates the Homeostasis of Intracellular Reactive Oxygen Species , 2010, PloS one.

[17]  Christopher A. Jones,et al.  The Cerebral Cavernous Malformation signaling pathway promotes vascular integrity via Rho GTPases , 2009, Nature Medicine.

[18]  A. Benz,et al.  Regulation of β1 integrin-Klf2-mediated angiogenesis by CCM proteins. , 2015, Developmental cell.

[19]  U. Felbor,et al.  Highly variable intrafamilial manifestations of a CCM3 mutation ranging from acute childhood cerebral haemorrhage to late-onset meningiomas , 2015, Clinical Neurology and Neurosurgery.

[20]  F. Chapon,et al.  CCM3 Mutations Are Associated with Early-Onset Cerebral Hemorrhage and Multiple Meningiomas , 2013, Molecular Syndromology.

[21]  J. Weber,et al.  Refined localization of the cerebral cavernous malformation gene (CCM1) to a 4-cM interval of chromosome 7q contained in a well-defined YAC contig. , 1995, Genome research.

[22]  L. Morrison,et al.  Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1 , 2016, Free radical biology & medicine.

[23]  L. Morrison,et al.  A locus for cerebral cavernous malformations maps to chromosome 7q in two families. , 1995, Genomics.

[24]  Ying Zhang,et al.  Structural Insights into the Molecular Recognition between Cerebral Cavernous Malformation 2 and Mitogen-Activated Protein Kinase Kinase Kinase 3. , 2015, Structure.

[25]  Ulrich Sure,et al.  Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling , 2010, Proceedings of the National Academy of Sciences.

[26]  T. Mayadas,et al.  The cerebral cavernous malformation proteins CCM2L and CCM2 prevent the activation of the MAP kinase MEKK3 , 2015, Proceedings of the National Academy of Sciences.

[27]  M. Preul,et al.  Cerebral cavernous malformations : from genes to proteins to disease Clinical article , 2011 .

[28]  E. Tournier-Lasserve,et al.  Cerebral Cavernous Malformation-1 Protein Controls DLL4-Notch3 Signaling Between the Endothelium and Pericytes , 2015, Stroke.

[29]  I. Awad,et al.  Mapping a gene causing cerebral cavernous malformation to 7q11.2-q21. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. W. Thomas,et al.  Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). , 1999, Human molecular genetics.

[31]  N. Sciaky,et al.  Cerebral Cavernous Malformation 2 Protein Promotes Smad Ubiquitin Regulatory Factor 1-mediated RhoA Degradation in Endothelial Cells , 2009, Journal of Biological Chemistry.

[32]  M. Ginsberg,et al.  KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell–cell junctions , 2007, The Journal of cell biology.

[33]  R. Fulton,et al.  A human chromosome 7 yeast artificial chromosome (YAC) resource: construction, characterization, and screening. , 1995, Genomics.

[34]  R. Fässler,et al.  Disruption of Focal Adhesions by Integrin Cytoplasmic Domain-associated Protein-1α* , 2003, The Journal of Biological Chemistry.

[35]  M. Ginsberg,et al.  Structural basis of the junctional anchorage of the cerebral cavernous malformations complex , 2012, The Journal of cell biology.

[36]  W. Sessa,et al.  CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations. , 2010, The Journal of clinical investigation.

[37]  G. Johnson,et al.  Cerebral cavernous malformation is a vascular disease associated with activated RhoA signaling , 2013, Biological chemistry.

[38]  J. Mably,et al.  ccm2-like is required for cardiovascular development as a novel component of the Heg-CCM pathway. , 2013, Developmental biology.

[39]  Wei Pan,et al.  Cerebral Cavernous Malformations Arise Independent of the Heart of Glass Receptor , 2014, Stroke.

[40]  R. Pallini,et al.  Endothelial Cells Lining Sporadic Cerebral Cavernous Malformation Cavernomas Undergo Endothelial-to-Mesenchymal Transition , 2016, Stroke.

[41]  J. Testa,et al.  Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22 , 1997, Oncogene.

[42]  Andrea Mosca,et al.  PDCD10 Gene Mutations in Multiple Cerebral Cavernous Malformations , 2014, PloS one.

[43]  Dean Y. Li,et al.  The cerebral cavernous malformation pathway controls cardiac development via regulation of endocardial MEKK3 signaling and KLF expression. , 2015, Developmental cell.

[44]  T. Boggon,et al.  CCM2–CCM3 interaction stabilizes their protein expression and permits endothelial network formation , 2015, The Journal of cell biology.

[45]  N. Sciaky,et al.  Rho Kinase Inhibition Rescues the Endothelial Cell Cerebral Cavernous Malformation Phenotype* , 2010, The Journal of Biological Chemistry.

[46]  M. Clanet,et al.  Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. , 2005, American journal of human genetics.

[47]  P. Frérebeau,et al.  Mutations within the MGC4607 gene cause cerebral cavernous malformations. , 2004, American journal of human genetics.

[48]  A. Joutel,et al.  Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas , 1999, Nature Genetics.

[49]  T. Boggon,et al.  Mechanism for KRIT1 release of ICAP1-mediated suppression of integrin activation. , 2013, Molecular cell.